CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
Erchonia GLS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01292538
NCT01292538N/ACompleted
CompareCT.gov

A Double-blind, Placebo-controlled Randomized Evaluation of the Effect of the Erchonia Scanner Device (GLS) Green Diode on Body Contouring of the Waist, Hips and Thighs

Erchonia Corporation·interventional·Posted Feb 9, 2011·Updated Feb 10, 2020

In Brief

A clinical study evaluating Erchonia GLS and Placebo laser for Body Contouring. Completed, enrolled 67 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if 532nm green diode laser light is effective in body contouring of the waist, hips and thighs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Contouring
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 9, 2011
Enrollment StartFeb 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.4 years ago

Interventions

Erchonia GLSdevice

532 nm green diode low level laser light device

Placebo laserdevice

Sham light output with no therapeutic benefit